| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K24690302 |
| PharmacoGx | BRD-K24690302 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PXN | CTRPv2 | pan-cancer | AAC | -0.21 | 2e-07 |
| mRNA | TNFRSF12A | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-05 |
| mRNA | SP100 | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-06 |
| mRNA | SSH1 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0003 |
| mRNA | RP11-426L16.10 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0001 |
| mRNA | RHOC | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0001 |
| mRNA | FHL2 | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-05 |
| mRNA | SUGT1 | CTRPv2 | pan-cancer | AAC | -0.16 | 8e-06 |
| mRNA | MGLL | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-05 |
| mRNA | SDC4 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0003 |
